CAS 72496-41-4 appears in our catalog under these names: Pirarubicin, >95% (HPLC), Pirarubicin/ 98.66% (existing batch purity), Pirarubicin, Pirarubicin, 95%, (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione, 98%, 98%. Offered by: TRC, TargetMol, GLPBio, Biosynth, Thermo Scientific (Acros). Available pack sizes: 10mg, 50mg, 5mg, 25mg, 100mg, 200mg, 10mM (in 1ml dmso), 250mg.
Pirarubicin is an anthracycline that is doxorubicin in which the hydroxy group at position 4' is replaced by a (2R)-tetrahydro-2H-pyran-2-yloxy group. It has a role as an antineoplastic agent and a cardiotoxic agent. It is a primary alpha-hydroxy ketone, a tertiary alpha-hydroxy ketone, a member of p-quinones, a deoxy hexoside, a member of oxanes, an aminoglycoside, an anthracycline, a member of tetracenequinones and a monosaccharide derivative. It is functionally related to a doxorubicin.
Source: ChEBI
| Molecular formula | C32H37NO12 |
|---|---|
| Molecular weight | 627.6 g/mol |
| IUPAC name | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| InChIKey | KMSKQZKKOZQFFG-YXRRJAAWSA-N |
| SMILES | C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O[C@@H]6CCCCO6 |
Computed by PubChem (NCBI)